ACAD: ACADIA Pharmaceuticals Inc

ACAD haberleri

• 16:27 Axsome Shares Up 20% in a Month: How Should You Play the Stock?
• 20:12 Acadia Pharmaceuticals appoints Katcheves as chief business officer
• 14:38 Acadia Pharmaceuticals stock hits 52-week high at $25.90
• 13:49 JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug
• 20:52 Mizuho lowers Acadia Pharmaceuticals stock price target to $22 from $32
• 13:56 Acadia Pharmaceuticals stock hits 52-week high at 25.24 USD
• 14:41 Acadia Pharmaceuticals stock price target raised to $24 from $18 at Stifel
• 14:04 Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth
• 12:02 Mizuho raises Acadia Pharmaceuticals stock price target on solid earnings
• 08:57 Acadia Pharmaceuticals stock price target raised to $38 from $37 at Citizens JMP
• 21:20 Acadia Pharmaceuticals Q2 2025 slides: revenue up 9%, raises full-year guidance
• 21:15 Acadia Pharmaceuticals (ACAD) Tops Q2 Earnings and Revenue Estimates
• 22:00 Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Beats Revenue Estimates
• 13:32 Catalyst Pharmaceutics to Report Q2 Earnings: What's in the Cards?
• 16:23 Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
• 15:07 Sarepta to Report Q2 Earnings: What's in Store for the Stock?
• 15:40 GMAB vs. ACAD: Which Stock Is the Better Value Option?
• 14:00 Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
• 08:32 ACADIA Pharmaceutical: ACP-101 Read-Out Is Not Fully Priced In (NASDAQ:ACAD)
• 12:00 Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
• 14:49 Acadia stock price target raised to $32 from $22 at UBS on growth outlook
• 11:36 Acadia Pharmaceuticals stock rating reiterated by H.C. Wainwright
• 13:21 Acadia stock maintains outperform rating at RBC on pipeline potential
• 12:55 Acadia Pharmaceuticals stock maintains outperform rating at BMO Capital